Strata Critical Medical, Inc. Class A Common Stock SRTA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $67.38M+0.9% | $66.79M+35.5% | $49.3M-30.4% | $70.8M+97.0% | $35.95M-1.2% | ||
| $53.27M-3.4% | $55.12M+46.3% | $37.68M-29.0% | $53.06M+83.6% | $28.9M-7.9% | ||
| $14.12M+21.0% | $11.67M+0.5% | $11.61M-34.5% | $17.74M+151% | $7.05M+40.7% | ||
| 21%+3.5pp | 17.5%-6.1pp | 23.6%-1.5pp | 25.1%+5.4pp | 19.6%+5.8pp | ||
| $15.61M— | —— | —— | —— | $12.33M-3.0% | ||
| $1.49M-50.6% | $3.01M+76.5% | $1.7M-4.1% | $1.78M+335% | $408K+29.7% | ||
| $17.09M— | —— | —— | —— | $12.74M-2.2% | ||
| $17.09M— | —— | —— | —— | $12.74M-2.2% | ||
| -$2.97M+53.6% | -$6.41M-13.9% | -$5.62M-13.5% | -$4.95M+12.9% | -$5.69M+3.7% | ||
| -4.4%+5.2pp | -9.6%+1.8pp | -11.4%-4.4pp | -7%+8.8pp | -15.8%+0.4pp | ||
| $473K-25.9% | $638K-43.4% | $1.13M-2.4% | $1.16M-12.6% | $1.32M-16.9% | ||
| $5.38M+429% | $1.02M+125% | -$4.04M-428% | $1.23M-69.8% | $4.07M— | ||
| $2.4M+145% | -$5.39M+44.2% | -$9.66M-159% | -$3.72M-131% | -$1.61M+78.3% | ||
| $0— | $0— | $0-100% | $21K— | $0— | ||
| $2.15M— | —— | $57.42M+1,634% | -$3.74M-7.2% | -$3.49M+64.3% | ||
| 3.2%— | —— | 116.5%+122pp | -5.3%+4.4pp | -9.7%+17.2pp | ||
| $0.03+100% | -$5,388,000.00+44.2% | -$9,657,000.00-92.3% | -$5,020,999.98-25,104,999,800% | -$0.02+100.0% | ||
| $0.00— | —— | $0.81— | —— | -$0.02+33.3% | ||
| $0.03— | —— | $0.70+1,500% | -$0.05-25.0% | -$0.04+66.7% | ||
| $0.03— | —— | $0.70+1,500% | -$0.05-25.0% | -$0.04+66.7% | ||
| 90.2M+9.8% | 82.1M-0.4% | 82.5M+1.4% | 81.3M+1.8% | 79.9M+3.1% | ||
| 85.3M+3.9% | 82.1M-0.4% | 82.5M+1.4% | 81.3M+1.8% | 79.9M+3.1% | ||
| -$3.44M— | —— | —— | —— | $0— | ||
| $473K-25.9% | $638K-43.4% | $1.13M-2.4% | $1.16M-12.6% | $1.32M-16.9% | ||
| $0.03+150% | -$0.06+50.0% | -$0.12-200% | -$0.04-100% | -$0.02+80.0% | ||
| $0.03+150% | -$0.06+50.0% | -$0.12-200% | -$0.04-100% | -$0.02+80.0% | ||
| $1.49M— | —— | —— | —— | $408K+29.7% | ||
| $2.4M+145% | -$5.39M+44.2% | -$9.66M-183% | -$3.41M-111% | -$1.61M+78.3% | ||
| $67.38M+0.9% | $66.79M+35.5% | $49.3M-30.4% | $70.8M+97.0% | $35.95M-1.2% | ||
| -$2.97M+53.6% | -$6.41M-13.9% | -$5.62M-13.5% | -$4.95M+12.9% | -$5.69M+3.7% | ||
| $86K+103% | -$3.4M+13.3% | -$3.92M-23.3% | -$3.18M+20.3% | -$3.99M+8.8% | ||
| $86K+103% | -$3.4M+13.3% | -$3.92M-23.3% | -$3.18M+20.3% | -$3.99M+8.8% | ||
| 0.1%+5.2pp | -5.1%+2.9pp | -7.9%-3.5pp | -4.5%+6.6pp | -11.1%+0.9pp | ||
| -$2.97M+53.6% | -$6.41M-13.9% | -$5.62M-13.5% | -$4.95M+12.9% | -$5.69M+3.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Strata Critical Medical, Inc. Class A Common Stock's revenue?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated $254.3M in revenue over the trailing twelve months, up 44.2% year over year.
- Is Strata Critical Medical, Inc. Class A Common Stock profitable?
- Strata Critical Medical, Inc. Class A Common Stock reported $52.3M in net income over the trailing twelve months, a 21.0% net margin.
- What are Strata Critical Medical, Inc. Class A Common Stock's profit margins?
- Gross margin is 21.7% and operating margin is -7.8%, with a 21.0% net margin.
- What is Strata Critical Medical, Inc. Class A Common Stock's earnings per share?
- Strata Critical Medical, Inc. Class A Common Stock's diluted EPS over the trailing twelve months is $0.64.
- Where does Strata Critical Medical, Inc. Class A Common Stock's income statement data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
